Formaldehyde is a simple, highly reactive aldehyde whose inhalation toxicity has been characterized through more than five decades of human, animal, and mechanistic research. Across this literature, inhalation was illustrated to follow a concentration-dependent continuum of effects confined to the tissues of initial contact. Controlled human chamber studies reported no measurable pulmonary impairment below 0.3 ppm, the onset of mild ocular and nasal irritation at 0.3 to 0.5 ppm, and reversible sensory irritation observed at concentrations approaching 1 ppm. These findings were consistent with observations from community and occupational investigations. Chronic inhalation bioassays in rats and mice identified a sharp transition between adaptive epithelial responses and sustained cytotoxic injury within the nasal epithelium. Continuous exposure to concentrations ≤2 ppm produced minimal and reversible histopathologic changes, whereas exposures ≥6 ppm were associated with persistent epithelial necrosis, regenerative proliferation, and nasal squamous cell carcinomas localized to regions of highest vapor flux in the rat nasal cavity. In these studies, tumors were not observed at concentrations that did not overwhelm local tissue repair capacity. Computational dosimetry, DNA-protein crosslink kinetics, and biologically based dose-response (BBDR) modeling indicated that these outcomes arose from localized tissue injury rather than from cumulative systemic dose. Despite the extensive experimental database, disagreement has persisted for several decades regarding the appropriate approach for conducting a quantitative risk assessment of formaldehyde. Its non-linear, concentration-response, high endogenous background levels, and pronounced interspecies differences would indicate that the use of the Linear-No-Threshold (LNT) model is not appropriate for identifying acceptable levels of exposure. Nonetheless, EPA proposed an 8-hour occupational exposure value (OEV) of 0.11 ppm and 0.17 ppm for a 15-minute OEV. This review synthesizes the human, experimental, and mechanistic evidence underlying formaldehyde's acute and chronic inhalation toxicity. Using a classic approach to risk assessment, we propose that an OEV of 0.3 ppm (8 hr TWA) and a short-term limit (15 min) of 1.0 ppm are sufficiently low to protect the vast majority of workers from temporary irritation, as well as chronic effects (such as cancer). This recommendation is supported by three significant reviews of formaldehyde and at least seven rigorous human exposure studies conducted over the past 35 years.
Siracusa et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: